Horiba Medical UK has announced a significant development of its in vitro diagnostics product offering with the launch of its new Yumizen G range of instruments and reagents.
Marking a milestone in its new product development programme, the Yumizen G range extends Horiba Medical’s Haematology portfolio into the complementary field of Haemostasis – a new discipline for the company.
Horiba Medical has developed a reputation for expertise and excellence in blood cell analysis. This has been utilised to deliver the new and comprehensive range of Yumizen G systems and reagents for coagulation diagnostics.
Cleve Wright, Director of Horiba Medical UK, said: “By leveraging our extensive expertise in the Haematology field, we have significantly broadened our scope in blood disease analysis into a complementary discipline.”